907 related articles for article (PubMed ID: 28749386)
21. U-serrated immunodeposition pattern differentiates type VII collagen targeting bullous diseases from other subepidermal bullous autoimmune diseases.
Vodegel RM; Jonkman MF; Pas HH; de Jong MC
Br J Dermatol; 2004 Jul; 151(1):112-8. PubMed ID: 15270879
[TBL] [Abstract][Full Text] [Related]
22. Granulocyte-derived elastase and gelatinase B are required for dermal-epidermal separation induced by autoantibodies from patients with epidermolysis bullosa acquisita and bullous pemphigoid.
Shimanovich I; Mihai S; Oostingh GJ; Ilenchuk TT; Bröcker EB; Opdenakker G; Zillikens D; Sitaru C
J Pathol; 2004 Dec; 204(5):519-27. PubMed ID: 15538734
[TBL] [Abstract][Full Text] [Related]
23. Acquired epidermolysis bullosa with the clinical feature of Brunsting-Perry cicatricial bullous pemphigoid.
Kurzhals G; Stolz W; Meurer M; Kunze J; Braun-Falco O; Krieg T
Arch Dermatol; 1991 Mar; 127(3):391-5. PubMed ID: 1998371
[TBL] [Abstract][Full Text] [Related]
24. Autoantibodies to bullous pemphigoid and epidermolysis bullosa acquisita antigens in an infant.
Kawachi Y; Ikegami M; Hashimoto T; Matsumura K; Tanaka T; Otsuka F
Br J Dermatol; 1996 Sep; 135(3):443-7. PubMed ID: 8949441
[TBL] [Abstract][Full Text] [Related]
25. Direct immunofluorescence microscopy of 1 mol/L sodium chloride-treated patient skin.
Domloge-Hultsch N; Bisalbutra P; Gammon WR; Yancey KB
J Am Acad Dermatol; 1991 Jun; 24(6 Pt 1):946-51. PubMed ID: 1869682
[TBL] [Abstract][Full Text] [Related]
26. A Korean case of anti-p200 pemphigoid.
Cho SB; Kim SC
Yonsei Med J; 2003 Oct; 44(5):931-4. PubMed ID: 14584115
[TBL] [Abstract][Full Text] [Related]
27. Diagnostic value of indirect immunofluorescence on sodium chloride-split skin in differential diagnosis of subepidermal autoimmune bullous dermatoses.
Ghohestani RF; Nicolas JF; Rousselle P; Claudy AL
Arch Dermatol; 1997 Sep; 133(9):1102-7. PubMed ID: 9301587
[TBL] [Abstract][Full Text] [Related]
28. Bullous pemphigoid and epidermolysis bullosa acquisita. Differentiation by fluorescence overlay antigen mapping.
De Jong MC; Bruins S; Heeres K; Jonkman MF; Nieboer C; Boorsma DM; Pas HH; van der Meer JB
Arch Dermatol; 1996 Feb; 132(2):151-7. PubMed ID: 8629822
[TBL] [Abstract][Full Text] [Related]
29. Bullous pemphigoid with prominent milium formation.
Tsuruta D; Brzezinski P; Koga H; Ohata C; Furumura M; Hashimoto T
Acta Dermatovenerol Croat; 2013; 21(1):35-8. PubMed ID: 23683484
[TBL] [Abstract][Full Text] [Related]
30. A practical technique for differentiation of subepidermal bullous diseases: localization of in vivo-bound IgG by laser scanning confocal microscopy.
Wozniak K; Kazama T; Kowalewski C
Arch Dermatol; 2003 Aug; 139(8):1007-11. PubMed ID: 12925388
[TBL] [Abstract][Full Text] [Related]
31. [Anti-p200 pemphigoid: a spectacular response to dapsone].
Munsch C; Prey S; Joly P; Meyer N; Lamant L; Livideanu C; Viraben R; Paul C
Ann Dermatol Venereol; 2011 Nov; 138(11):739-42. PubMed ID: 22078034
[TBL] [Abstract][Full Text] [Related]
32. A subepidermal blistering disease with histopathological features of dermatitis herpetiformis and immunofluorescence characteristics of bullous pemphigoid: a novel subepidermal blistering disease or a variant of bullous pemphigoid?
Salmhofer W; Kawahara Y; Soyer HP; Kerl H; Nishikawa T; Hashimoto T
Br J Dermatol; 1997 Oct; 137(4):599-604. PubMed ID: 9390339
[TBL] [Abstract][Full Text] [Related]
33. IgA anti-p200 pemphigoid.
Wozniak K; Hashimoto T; Fukuda S; Ohyama B; Ishii N; Koga H; Dainichi T; Kowalewski C
Arch Dermatol; 2011 Nov; 147(11):1306-10. PubMed ID: 22106117
[TBL] [Abstract][Full Text] [Related]
34. A case of mixed bullous disease of epidermolysis bullosa acquisita and linear IgA bullous dermatosis.
Osawa M; Demitsu T; Toda S; Yokokura H; Umemoto N; Yamada T; Yoneda K; Kakurai M; Yoshida M; Hashimoto T
Dermatology; 2005; 211(2):146-8. PubMed ID: 16088162
[TBL] [Abstract][Full Text] [Related]
35. Identification of a novel basement membrane antigen (p84) defined by sera with antibodies to both the epidermal and dermal side of split skin.
Gao SQ; Bystryn JC
J Invest Dermatol; 1994 Feb; 102(2):236-40. PubMed ID: 8106753
[TBL] [Abstract][Full Text] [Related]
36. Repeat direct immunofluorescence to discriminate pemphigoid from epidermolysis bullosa acquisita.
Wuepper KD
Arch Dermatol; 1990 Oct; 126(10):1365. PubMed ID: 2221945
[No Abstract] [Full Text] [Related]
37. Retrospective study of the clinical, histologic, and immunologic features of epidermolysis bullosa acquisita in 9 patients.
Barreiro-Capurro A; Mascaró-Galy JM; Iranzo P
Actas Dermosifiliogr; 2013 Dec; 104(10):904-14. PubMed ID: 23895729
[TBL] [Abstract][Full Text] [Related]
38. Skin explant culture: a reliable method for detecting pemphigoid antibodies in pemphigoid sera that are negative by standard immunofluorescence and immunoblotting.
Mutasim DF; Vaughan A; Supapannachart N; Farooqui J
J Invest Dermatol; 1993 Oct; 101(4):624-7. PubMed ID: 8409535
[TBL] [Abstract][Full Text] [Related]
39. Use of animal skin substrates for indirect immunofluorescence diagnosis of subepidermal autoimmune bullous diseases.
Kanitakis J; Cozzani E; Peyron E; Bourchany D; Claudy A
Arch Dermatol; 1994 Dec; 130(12):1558. PubMed ID: 7986134
[No Abstract] [Full Text] [Related]
40. The use of Biochip immunofluorescence microscopy for the serological diagnosis of epidermolysis bullosa acquisita.
Marzano AV; Cozzani E; Biasin M; Russo I; Alaibac M
Arch Dermatol Res; 2016 May; 308(4):273-6. PubMed ID: 26895535
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
